ACTRN12610000550000尚未招募4 期
Comparison of the effectiveness of carbetocin vs oxytocin in managing the third stage of labor in a group of women with risk factors for postpartum hemorrhage.
milton gomez0 个研究点目标入组 140 人开始时间: 2010年7月8日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- Female
入选标准
- •1. Pregnancy over 34 weeks.
- •2. Hold at history a risk factor for postpartum haemorrhague as nulliparous, multiple pregnancy, hypertensive disease, induction of labor, fetal macrosomia fetus, more than 35 years, obesity, second period of prolonged labor, precipitate labor, chorioamnionitis and prolonged third period of labor.
排除标准
- •1. Mental retardation.
- •2. Coagulation disorder.
- •3. Renal failure.
- •4. Liver failure.
- •5. Heart failure.
- •6. Heart rhythm disorders.
- •7. Central placenta previa total.
- •8. Indication of caesarean.
研究者
相似试验
招募中
2 期
Comparison of two drugs, carbutocin and oxytocin, with and without tranexamic acid in cesarean section bleeding rateIRCT20240529061944N1Kashan University of Medical Sciences50
尚未招募
3 期
Comparing two drugs efficacy and safety in prevention of PPH in a computer generated randomisation techniqueCTRI/2024/01/061097DR SMRITI BAG
尚未招募
4 期
Comparing Carbetocin and Oxytocin for preventing bleeding in Postpartum womeCTRI/2024/07/071389Department of Obstetrics and Gynaecology AIIMS Bathinda
招募中
不适用
COMPARISON OF THE EFFECTIVENESS OF CARBETOCIN AND OXYTOCIN IN DECREASING POSTOPERATIVE BLOOD LOSS AMONG WOMEN UNDERGOING CAESAREAN SECTION IN WARRI, DELTA STATE, NIGERIA: A RANDOMIZED CONTROLLED TRIAL.PACTR202201739991276OKWUCHUKWU ONYEOWUZONI150
尚未招募
4 期
Comparing two drugs carbetocin and oxytocin in prevention of postpartum hemorrhage in a randomly selected deliveries in mother hospital. Oxytocin is routinely used drug instead of which we are using carbetocin also in selected patients and comparing their efficaciesCTRI/2022/11/047176DR BINDHU VARGHESE